Malignant Peritoneal Neoplasm Withdrawn Phase 2 Trials for Letrozole (DB01006)

Also known as: Peritoneal Cancer / Malignant neoplasm of peritoneum, unspecified / Malignant peritoneal neoplasm NOS

IndicationStatusPhase
DBCOND0073968 (Malignant Peritoneal Neoplasm)Withdrawn2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT00634894Femara (Letrozole) Versus Placebo for Patients With Ovarian, Fallopian Tube, or Primary Peritoneal CancerTreatment